These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 32596727)
21. Cardiovascular risk estimation with 5 different algorithms before and after 5 years of bDMARD treatment in rheumatoid arthritis. Cacciapaglia F; Fornaro M; Venerito V; Perniola S; Urso L; Iannone F Eur J Clin Invest; 2020 Dec; 50(12):e13343. PubMed ID: 32654116 [TBL] [Abstract][Full Text] [Related]
22. Chorea in primary antiphospholipid syndrome is associated with rheumatic fever. Appenzeller S; Yeh S; Maruyama M; Barros SM; de Carvalho JF Rheumatol Int; 2012 Sep; 32(9):2857-61. PubMed ID: 21881983 [TBL] [Abstract][Full Text] [Related]
23. High prevalence of diabetes in patients with rheumatoid arthritis: results from a questionnaire survey linked to claims data. Albrecht K; Luque Ramos A; Hoffmann F; Redeker I; Zink A Rheumatology (Oxford); 2018 Feb; 57(2):329-336. PubMed ID: 29121263 [TBL] [Abstract][Full Text] [Related]
24. Does depression increase the risk of stroke in patients with rheumatoid arthritis? A population-based cohort study. Tsai TY; Lu MC; Livneh H; Chiu SY; Lai NS; Guo HR BMJ Open; 2017 Jun; 7(4):e014233. PubMed ID: 28646083 [TBL] [Abstract][Full Text] [Related]
25. [Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome]. Reshetniak TM; Seredavkina nV; Mach ES; Aleksandrova EN; Novikov AA; Cherkasova MV; Nasonov EL Ter Arkh; 2008; 80(10):60-7. PubMed ID: 19105418 [TBL] [Abstract][Full Text] [Related]
26. Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. Joseph JE; Harrison P; Mackie IJ; Isenberg DA; Machin SJ Br J Haematol; 2001 Nov; 115(2):451-9. PubMed ID: 11703349 [TBL] [Abstract][Full Text] [Related]
27. Consensus statement on a framework for the management of comorbidity and extra-articular manifestations in rheumatoid arthritis. Loza E; Lajas C; Andreu JL; Balsa A; González-Álvaro I; Illera O; Jover JÁ; Mateo I; Orte J; Rivera J; Rodríguez Heredia JM; Romero F; Martínez-López JA; Ortiz AM; Toledano E; Villaverde V; Carmona L; Castañeda S Rheumatol Int; 2015 Mar; 35(3):445-58. PubMed ID: 25543267 [TBL] [Abstract][Full Text] [Related]
28. Prevalence of cardiovascular diseases and traditional cardiovascular risk factors in patients with rheumatoid arthritis: a real-life evidence from BioSTAR nationwide registry. Duruöz MT; Ataman Ş; Bodur H; Çay HF; Melikoğlu MA; Akgül Ö; Çapkın E; Gürer G; Çevik R; Göğüş FN; Kamanlı A; Yurdakul FG; Yağcı İ; Rezvani A; Altan L Rheumatol Int; 2024 Feb; 44(2):291-301. PubMed ID: 38157014 [TBL] [Abstract][Full Text] [Related]
30. Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database. Sfikakis PP; Bournia VK; Sidiropoulos P; Boumpas DT; Drosos AA; Kitas GD; Konstantonis G; Liossis SN; Manoussakis MN; Sakkas L; Tektonidou M; Tzioufas AG; Vlachoyiannopoulos PG; Kani C; Paterakis P; Litsa P; Vassilopoulos D Clin Exp Rheumatol; 2017; 35(4):579-585. PubMed ID: 28281458 [TBL] [Abstract][Full Text] [Related]
31. Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus. Tarr T; Lakos G; Bhattoa HP; Szegedi G; Shoenfeld Y; Kiss E Lupus; 2007; 16(5):324-8. PubMed ID: 17576733 [TBL] [Abstract][Full Text] [Related]
32. Methods to Develop an Electronic Medical Record Phenotype Algorithm to Compare the Risk of Coronary Artery Disease across 3 Chronic Disease Cohorts. Liao KP; Ananthakrishnan AN; Kumar V; Xia Z; Cagan A; Gainer VS; Goryachev S; Chen P; Savova GK; Agniel D; Churchill S; Lee J; Murphy SN; Plenge RM; Szolovits P; Kohane I; Shaw SY; Karlson EW; Cai T PLoS One; 2015; 10(8):e0136651. PubMed ID: 26301417 [TBL] [Abstract][Full Text] [Related]
34. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring in clinical practice: the spanish cohort of the COMORA study. Balsa A; Lojo-Oliveira L; Alperi-López M; García-Manrique M; Ordóñez-Cañizares C; Pérez L; Ruiz-Esquide V; Corrales A; Narváez J; Rey-Rey J; Rodríguez-Lozano C; Ojeda S; Muñoz-Fernández S; Nolla JM; García-Torrón J; Gamero F; García-Vicuña R; Hernández-Cruz B; Campos J; Rosas J; García-Llorente JF; Gómez-Centeno A; Cáliz R; Sanmartí R; Bermúdez A; Abasolo-Alcázar L; Fernández-Nebro A; Rodríguez-Rodríguez L; Marras C; González-Gay MÁ; Hmamouchi I; Martín-Mola E Reumatol Clin (Engl Ed); 2019; 15(2):102-108. PubMed ID: 28711461 [TBL] [Abstract][Full Text] [Related]
35. Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients. Vianna JL; Khamashta MA; Ordi-Ros J; Font J; Cervera R; Lopez-Soto A; Tolosa C; Franz J; Selva A; Ingelmo M Am J Med; 1994 Jan; 96(1):3-9. PubMed ID: 8304360 [TBL] [Abstract][Full Text] [Related]
36. Prognostic value of comorbidity indices and lung diseases in early rheumatoid arthritis: a UK population-based study. Nikiphorou E; de Lusignan S; Mallen C; Roberts J; Khavandi K; Bedarida G; Buckley CD; Galloway J; Raza K Rheumatology (Oxford); 2020 Jun; 59(6):1296-1305. PubMed ID: 31580449 [TBL] [Abstract][Full Text] [Related]
37. [A multicenter study of coronary artery disease and its risk factors in rheumatoid arthritis in China]. Li C; Wang XR; Tang YD; An Y; Zhou YS; Guo SW; Zhang XY; Duan TJ; Zhu JX; Li XF; Wang LZ; Wang CH; Wang YF; Yang R; Wang GC; Lu X; Zhu P; Chen LN; Jin HT; Liu JT; Liu XY; Sun L; Chen HY; Wei P; Wang JX; Cui LF; Shu R; Liu BL; Zhang ZL; Li GT; Li ZB; Yang J; Li JF; Jia B; Zhang FX; Tao JM; Han SL; Lin JY; Wei MQ; Liu XM; Ke D; Hu SX; Ye C; Yang XY; Li H; Huang CB; Gao M; Lai P; Li XF; Song LJ; Wang Y; Wang XY; Mu R; Su Y; Li ZG Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):176-81. PubMed ID: 22516983 [TBL] [Abstract][Full Text] [Related]
38. High prevalence of cardiovascular comorbidities in patients with rheumatoid arthritis from a population-based cross-sectional study of a Japanese health insurance database. Sakai R; Hirano F; Kihara M; Yokoyama W; Yamazaki H; Harada S; Nanki T; Koike R; Miyasaka N; Harigai M Mod Rheumatol; 2016 Jul; 26(4):522-8. PubMed ID: 26666766 [TBL] [Abstract][Full Text] [Related]
39. Prevalence and target attainment of traditional cardiovascular risk factors in patients with systemic lupus erythematosus: a cross-sectional study including 3401 individuals from 24 countries. Bolla E; Semb AG; Kerola AM; Ikdahl E; Petri M; Pons-Estel GJ; Karpouzas GA; Sfikakis PP; Quintana R; Misra DP; Borba EF; Garcia-de la Torre I; Popkova TV; Artim-Esen B; Troldborg A; Fragoso-Loyo H; Ajeganova S; Yazici A; Aroca-Martinez G; Direskeneli H; Ugarte-Gil MF; Mosca M; Goyal M; Svenungsson E; Macieira C; Hoi A; Lerang K; Costedoat-Chalumeau N; Tincani A; Mirrakhimov E; Acosta Colman I; Danza A; Massardo L; Blagojevic J; Yılmaz N; Tegzová D; Yavuz S; Korkmaz C; Hachulla E; Moreno Alvarez MJ; Muñoz-Louis R; Pantazis N; Tektonidou MG; Lancet Rheumatol; 2024 Jul; 6(7):e447-e459. PubMed ID: 38878780 [TBL] [Abstract][Full Text] [Related]
40. The prevalence of antibodies to anionic phospholipids in patients with the primary antiphospholipid syndrome, systemic lupus erythematosus and their relatives and spouses. Radway-Bright EL; Ravirajan CT; Isenberg DA Rheumatology (Oxford); 2000 Apr; 39(4):427-31. PubMed ID: 10817777 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]